431 related articles for article (PubMed ID: 16387546)
1. Is combination antiviral therapy for CMV superior to monotherapy?
Drew WL
J Clin Virol; 2006 Apr; 35(4):485-8. PubMed ID: 16387546
[TBL] [Abstract][Full Text] [Related]
2. Emergence and persistence of multiple antiviral-resistant CMV strains in a highly immunocompromised child.
Iwasenko JM; Scott GM; Ziegler JB; Rawlinson WD
J Clin Virol; 2007 Oct; 40(2):152-5. PubMed ID: 17698411
[TBL] [Abstract][Full Text] [Related]
3. Combination antiviral therapy for ganciclovir-resistant cytomegalovirus infection in solid-organ transplant recipients.
Mylonakis E; Kallas WM; Fishman JA
Clin Infect Dis; 2002 May; 34(10):1337-41. PubMed ID: 11981729
[TBL] [Abstract][Full Text] [Related]
4. A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.
Reddy AJ; Zaas AK; Hanson KE; Palmer SM
J Heart Lung Transplant; 2007 Dec; 26(12):1286-92. PubMed ID: 18096480
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy improves CMV treatment.
AIDS Alert; 1996 Mar; 11(3):32-3. PubMed ID: 11363244
[TBL] [Abstract][Full Text] [Related]
6. Therapy with a combination of intravitreal foscarnet and intravenous ganciclovir in clinically resistant cytomegalovirus retinitis and patients with acquired immunodeficiency syndrome.
Guembel HO; Hofmann F; van Even G; Cinatl J; Makabe R
Ger J Ophthalmol; 1996 Nov; 5(6):490-1. PubMed ID: 9479542
[No Abstract] [Full Text] [Related]
7. Assay of cytomegalovirus susceptibility to ganciclovir in renal and heart transplant recipients.
de Oña Navarro M; Melón S; Méndez S; Iglesias B; Palacio A; Bernardo MJ; Rodriguez-Lambert JL; Gómez E
Transpl Int; 2002 Nov; 15(11):570-3. PubMed ID: 12461662
[TBL] [Abstract][Full Text] [Related]
8. Resistance to combined ganciclovir and foscarnet therapy in a liver transplant recipient with possible dual-strain cytomegalovirus coinfection.
Rodriguez J; Casper K; Smallwood G; Stieber A; Fasola C; Lehneman J; Heffron T
Liver Transpl; 2007 Oct; 13(10):1396-400. PubMed ID: 17902124
[TBL] [Abstract][Full Text] [Related]
9. Intraocular therapy for cytomegalovirus retinitis.
Palestine AG
J Int Assoc Physicians AIDS Care; 1996 May; 2(5):25-8. PubMed ID: 11363527
[TBL] [Abstract][Full Text] [Related]
10. The treatment of AIDS-related cytomegalovirus disease with ganciclovir and foscarnet association. Three case reports.
Manfredi R; Mastroianni A; Coronado OV; Chiodo F
Recenti Prog Med; 1996 Nov; 87(11):545-8. PubMed ID: 9122537
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus UL97 mutations associated with ganciclovir resistance in immunocompromised patients from Argentina.
Sánchez Puch S; Ochoa C; Carballal G; Zala C; Cahn P; Brunet R; Salomón H; Videla C
J Clin Virol; 2004 Jul; 30(3):271-5. PubMed ID: 15135748
[TBL] [Abstract][Full Text] [Related]
12. CMV resistance: "more complicated than we thought".
Mascolini M
J Int Assoc Physicians AIDS Care; 1996 May; 2(5):37-9. PubMed ID: 11363529
[TBL] [Abstract][Full Text] [Related]
13. [Cytomegalovirus sensitivity to anti-retroviral agents in patients infected with the human immunodeficiency virus with chorioretinitis in Spain].
Cañizares MA; Losada I; Pérez-Elías MJ; González J; Rubio R; Casado JL; Guerrero A
Enferm Infecc Microbiol Clin; 2001 Dec; 19(10):471-4. PubMed ID: 11844451
[TBL] [Abstract][Full Text] [Related]
14. [Ganciclovir-resistant cytomegalovirus infection: 2 cases with different clinical impact].
Reusser P; Hostettler B; Attehbofer R
Schweiz Med Wochenschr; 1996 Oct; 126(42):1779-84. PubMed ID: 8966510
[TBL] [Abstract][Full Text] [Related]
15. A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients.
Mattes FM; Hainsworth EG; Geretti AM; Nebbia G; Prentice G; Potter M; Burroughs AK; Sweny P; Hassan-Walker AF; Okwuadi S; Sabin C; Amooty G; Brown VS; Grace SC; Emery VC; Griffiths PD
J Infect Dis; 2004 Apr; 189(8):1355-61. PubMed ID: 15073671
[TBL] [Abstract][Full Text] [Related]
16. Treatment of cytomegalovirus esophagitis in patients with acquired immune deficiency syndrome: a randomized controlled study of foscarnet versus ganciclovir. The Italian Cytomegalovirus Study Group.
Parente F; Bianchi Porro G
Am J Gastroenterol; 1998 Mar; 93(3):317-22. PubMed ID: 9517631
[TBL] [Abstract][Full Text] [Related]
17. A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients.
Shereck EB; Cooney E; van de Ven C; Della-Lotta P; Cairo MS
Pediatr Blood Cancer; 2007 Sep; 49(3):306-12. PubMed ID: 16972242
[TBL] [Abstract][Full Text] [Related]
18. Treatment of refractory CMV-infection following hematopoietic stem cell transplantation with the combination of foscarnet and leflunomide.
Ehlert K; Groll AH; Kuehn J; Vormoor J
Klin Padiatr; 2006; 218(3):180-4. PubMed ID: 16688677
[TBL] [Abstract][Full Text] [Related]
19. Combination antiviral therapy for cytomegalovirus disease in patients with AIDS.
Cline JJ; Garrett AD
Ann Pharmacother; 1997 Sep; 31(9):1080-2. PubMed ID: 9296250
[TBL] [Abstract][Full Text] [Related]
20. The influence of mixed HCMV UL97 wildtype and mutant strains on ganciclovir susceptibility in a cell associated plaque reduction assay.
Eckle T; Jahn G; Hamprecht K
J Clin Virol; 2004 May; 30(1):50-6. PubMed ID: 15072754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
